Maggie Leung

The COVID-19 pandemic has seen over 63 million confirmed cases and over 1 million deaths globally. Ever since the start of the pandemic, the development of a safe and effective vaccine against SARS-CoV-2 – the coronavirus responsible for COVID-19 – has been the priority of public health and researchers worldwide. For scientists at a lab at Stanford University in the United States, biochemist Peter S.

Abstract : Neuroinflammation is the precursor for several neurodegenerative diseases (NDDs), such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and multiple sclerosis (MS). Targeting neuroinflammation has emerged as a promising strategy to address a wide range of CNS pathologies. These NDDs still present significant challenges in terms of limited and ineffective diagnosis and treatment options, driving the need to explore innovative and novel therapeutic alternatives.